|Articles|November 15, 2002
- BioPharm International-11-01-2002
- Volume 15
- Issue 11
European Editor's Report ? An Industry Comes of Age
Author(s)Kevin Robinson
by Kevin Robinson, BioPharm International As we approach the end of 2002, biotechnology companies continue to be the standard bearers for innovation in the pharmaceutical industry.
Advertisement
Articles in this issue
about 23 years ago
Inside Washington: Major Changes Ahead for FDAabout 23 years ago
Bioinformatics Databases ? Questions of Copyrightabout 23 years ago
Guest Editorial: Back to the Beginningabout 23 years ago
You Have Failed . . . A Case Study in Warning Letter Remediationabout 23 years ago
Survival Guide to FDA Inspections: Part 3, Responding to ObservationsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Formulation Strategies, Tech Advances, Challenges, and Considerations in Novel Drug Delivery
2
BioPharm Weekly News Roundup—Week of Nov. 24, 2025
3
Op-Ed: Why the US Must Move Beyond Its mRNA Monoculture
4
What a $2 Billion Maryland Expansion Means for the Future of Biologics Production
5
